The NHAS set key targets in 2010 to reduce HIV incidence by 25 percent and the HIV transmission rate by 30 percent by 2015.
According to the researchers’ findings, the number of new HIV infections decreased from 37,366 to 33,218 between 2010 and 2015, an 11.1 percent drop. HIV transmission rates also decreased during the time period studied, from 3.16 percent to 2.61 percent, a 17.3 percent drop.
Despite missing the mark by a “sizable margin,” lead author Robert Bonacci says the results are promising.
“Scaling up HIV treatment and care alone was not enough,” said Mr. Bonacci. “We need a simultaneous expansion of diagnostic and prevention services, paired with an intensified focus on communities disproportionately affected by HIV — particularly gay men, young people, transgender people, African-American and Hispanic communities, and those who live in the southern U.S., to sufficiently impact the HIV epidemic.”
More articles on HIV:
Employee sues hospitals for allegedly revealing HIV status during security breach
Johns Hopkins performs world’s first HIV-positive to HIV-positive liver transplant
Gene editing could deliver HIV cure: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
